China Tracker - Details for WuXi PharmaTech (WX)

 WuXi PharmaTech
 Basic Facts and History
Data Source: Annual Report for the period ended 2009-12-31
Reporting Type: Foreign Company (20-F Filings) 
Incorporation: Cayman Islands 
Corporate Headquarters: USA (Shanghai) 
Going Public: IPO on 2007-08-09 
IPO Price: $14.00 (-100.00% since IPO)
IPO Lead Underwriter: Credit Suisse 
Main Operating Subsidiary: WuXi PharmaTech Co., founded 2000 
Investor Relations: Investor Relations Website 
Internal Controls: effective 
Internal Controls Audit: not performed 
 
 Fiscal Year
Fiscal Year ends: December 31 
Annual Report 20-F: due by June 30 
WX
Healthcare & Drugs
SCORE
2
READ: Score Cards Explained
Current Price:  n/a
F10k Day (2007-08-09): -100.00%$19.60
2009 Close: -100.00%$15.96
2010 Close: -100.00%$16.14
2011 Close: -100.00%$11.04
High (2012-08-14): -100.00%$15.19
Low (2012-07-27): -100.00%$13.00
Exchange: NYQ
Market Capitalization: n/a
Total Shares: 74.59 mill
Float: n/a
Avg Volume: 455.00 k
Short Interest: 365.80 k
Short Ratio: 0.72%0.8 d
Last Quarter: 2010-06-30
Revenue (MRQ): 81.04 mill
Net Income (MRQ): 19.91 mill
all financial data provided without warranty